ArticleCancers2024

Sialylation Inhibition Can Partially Revert Acquired Resistance to Enzalutamide in Prostate Cancer Cells.

Emily Archer Goode et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.